Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.

CSE:BRAX - Post by User

Braxia Scientific Corp > 2022 potential?

<< Previous

Bullboard Posts

Next >>

Post by Petespipeon Feb 20, 2022 9:56am

291 Views

Post# 34446101

2022 potential?

This company is in the business of treating depression, which is a huge Market. Ironically this companies share price has caused depression for it's shareholders. Any thoughts on the current management team and future of this company?

<< Previous

Bullboard Posts

Next >>

Fortuna reports record earnings for Q3 2024